The Euronext Amsterdam stock exchange has successfully secured the initial public offering of a major European biotechnology firm, beating out competing exchanges in London and Frankfurt. The successful listing highlights the continued attractiveness of Amsterdam as a primary financial center for European life sciences and technology companies seeking access to international capital markets.